Alisa S Vologzhannikova

9PUBLICATIONS
27CO-AUTHORS
Haematological tumoursMolecular targetsAutoimmunityBiomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 02, 2025
A role of pigment epithelium-derived factor in zinc-mediated mechanism of neurodegeneration in glaucoma.

Dmitry V Chistyakov, Anatolii S Belousov, Marina P Shevelyova

|May 14, 2025
Interaction Between Glucagon-like Peptide 1 and Its Analogs with Amyloid-β Peptide Affects Its Fibrillation and Cytotoxicity.

Ekaterina A Litus, Marina P Shevelyova, Alisa A Vologzhannikova

|Mar 28, 2025
Binding of Pro-Inflammatory Proteins S100A8 or S100A9 to Amyloid-β Peptide Suppresses Its Fibrillation.

Ekaterina A Litus, Marina P Shevelyova, Alisa A Vologzhannikova

|May 11, 2024
In Search for Low-Molecular-Weight Ligands of Human Serum Albumin That Affect Its Affinity for Monomeric Amyloid β Peptide.

Evgenia I Deryusheva, Marina P Shevelyova, Victoria A Rastrygina

|Dec 23, 2022
Specific S100 Proteins Bind Tumor Necrosis Factor and Inhibit Its Activity.

Alexey S Kazakov, Marina Y Zemskova, Gleb K Rystsov

|Dec 24, 2021
Mechanism of Zn2+ and Ca2+ Binding to Human S100A1.

Viktoriia E Baksheeva, Andrei Yu Roman, Claude Villard

Pageof 2